1. Ovarian cancer;Yancik;Age contrasts in incidence, histology, disease stage at diagnosis, and mortality. Cancer,1993
2. Utility of anti-carcinoembryonic antigen monoclonal antibodies for differentiating ovarian adenocarcinomas from gastrointestinal metastasis to the ovary;Pavelic;Gynecol Oncol,1991
3. Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience;Omura;J Clin Oncol,1991
4. Meta-analysis of cisplatin, doxorubicin, and cyclophosphamide versus cisplatin and cyclophosphamide chemotherapy of ovarian carcinoma;Omura;Obstet Gynecol,1993
5. Wagner, U, Kohler, S, Reinartz, S, Giffels, P, Huober, J, Renke, K, Schlebusch, H, Biersack, H, J, Mobus, V, Kreienberg, R, Bauknecht, T, Krebs, D, Wallwiener, D, Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125: immune responses and survival in palliative treatment.